Page last updated: 2024-11-02

moxonidine and Hyperglycemia, Postprandial

moxonidine has been researched along with Hyperglycemia, Postprandial in 1 studies

moxonidine: structure given in first source

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research Excerpts

ExcerptRelevanceReference
"Moxonidine treatment enhanced the expression of IRS-1 protein in skeletal muscle by 74% in SHROB and 40% in SHR."1.30Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. ( Bedol, D; Ernsberger, P; Farrell, CJ; Friedman, JE; Ishizuka, T; Koletsky, RJ; Liu, S, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, JE1
Ishizuka, T1
Liu, S1
Farrell, CJ1
Koletsky, RJ1
Bedol, D1
Ernsberger, P1

Other Studies

1 other study available for moxonidine and Hyperglycemia, Postprandial

ArticleYear
Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.
    Blood pressure. Supplement, 1998, Volume: 3

    Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Female; Hyperglycemia; Hypertension; Hypog

1998